McKinney W P, Schiedermayer D L, Lurie N, Simpson D E, Goodman J L, Rich E C
Division of General Internal Medicine, Medical College of Wisconsin, Milwaukee.
JAMA. 1990 Oct 3;264(13):1693-7.
We surveyed faculty and residents from seven hospitals affiliated with three academic internal medicine training programs about their perceptions of the informational and service benefits vs the risks of ethical compromise involved in interactions with pharmaceutical sales representatives. Questionnaires were returned by 467 (81%) of 575 physicians surveyed. Residents and faculty generally had somewhat negative attitudes toward the educational and informational value of detailing activities at their institutions but indicated that representatives supported important conferences and speakers. Residents were more likely than faculty to perceive contacts with sales representatives as potentially influencing physician decision making. Sixty-seven percent of faculty and 77% of residents indicated that physicians could be compromised by accepting gifts. More than half of the physicians who suggested that such compromise was possible indicated that acceptance of gifts worth more than +100 from drug companies would be likely to compromise a physician's independence and objectivity. A majority of both faculty and house staff favored eliminating presentations by pharmaceutical representatives at their hospitals. Only 10% thought they had had sufficient training during medical school and residency regarding professional interaction with sales representatives.
我们对隶属于三个学术性内科培训项目的七家医院的教员和住院医师进行了调查，询问他们对于与制药公司销售代表互动中所涉及的信息和服务益处以及道德妥协风险的看法。在接受调查的575名医生中，有467人（81%）回复了问卷。住院医师和教员对所在机构中推广活动的教育和信息价值总体持 somewhat 负面态度，但表示销售代表支持重要会议和演讲者。与教员相比，住院医师更有可能认为与销售代表的接触可能会影响医生的决策。67%的教员和77%的住院医师表示，医生可能会因接受礼物而受到影响。超过一半认为可能存在这种影响的医生表示，接受制药公司价值超过100的礼物可能会损害医生的独立性和客观性。大多数教员和住院医师都赞成取消制药公司销售代表在他们医院的演示。只有10%的人认为他们在医学院和住院医师培训期间接受了关于与销售代表进行专业互动的充分培训。
